Orthopaedics and Trauma
Volume 23, Issue 5 , Pages 342-349 , October 2009

(vi) Management of periprosthetic infection in total hip arthroplasty

References 

  1. Charnley JA. clean-air operating enclosure. Br J Surg. 1964;51:202–205
  2. Kaltsas D. Infection after total hip arthroplasty. Ann R Coll Surg Engl. 2004;86:267–271
  3. Wolfe RM. Total hip arthroplasty revision for sepsis. Trauma. 2002;43:29–47
  4. Dreghorn CR, Hamblen DL. Revision arthroplasty: a high price to pay. 11 Br Med J. 1989;298(6674):648–649
  5. Burnett RS, Kelly MA, Hanssen AD, Barrack RL. Technique and timing of two-stage exchange for Infection in TKA. Clin Orthop Relat Res. 2007;464:164–178
  6. Luessenhop CP, Higgins LD, Brause BD, Ranawat CS. Multiple prosthetic infections after total joint arthroplasty. Risk factor analysis. J Arthroplasty. 1996;11(7):862–868
  7. Della Valle CJ, Zuckerman JD, Di Cesare PE. Perioperative sepsis. Clin Orthop Relat Res. 2004;420:26–31
  8. Haddad FS, Masri BA, Garbuz DS, Duncan CP. The treatment of the infected hip replacement, the complex case. Clin Orthop Relat Res. 1999;369:144–156
  9. Charnley J. Postoperative infections after total hip replacement with special reference to air contamination in the operating room. Clin Orthop. 1972;87:167–187
  10. Ha'eri GB, Wiley AM. Total hip replacement in a laminar flow environment with special reference to deep infection. Clin Orthop. 1980;148:163–168
  11. HCh Vogely, Fleer A, Dhert WJA, Verbout AJ. Infection of an orthopaedic implant: epidemiology and diagnosis. Rev Med Microbiol. 2000;11(3):115–125
  12. Nestor BJ, Hanssen AD, Ferrer-Gonzalez R, Fitzgerald RH. The use of porous prostheses in delayed reconstruction of total hip replacements that have failed because of infection. J Bone Joint Surg. 1994;76A:349–358
  13. Costerton JW, Lewandowski Z, Caldwell DE, et al. Microbial biofilms. Annu Rev Microbiol. 1995;49:711–745
  14. Hanssen AD, Osmon DR. Prevention of deep wound infection after total hip arthroplasty: the role of prophylactic antibiotics and clean air technology. Semin Arthroplasty. 1994;5(3):114–121
  15. AlBuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br. 2008;90(7):915–920
  16. Al-Maiyah M, Hill D, Bajwa A, Slater S, et al. Bacterial contaminants and antibiotic prophylaxis in total hip arthroplasty. J Bone Joint Surg Br. 2005;87(9):1256–1259
  17. Cranny G, Elliott R, Weatherly H, et al. A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery. Health Technol Assess. 2008;12(1):1366–5278
  18. Orthopaedic knowledge update. 3rd ed.. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2006;
  19. Penner MJ, Duncan CP, Masri BA. The in vitro elution characteristics of antibiotic-loaded CMW and Palacos-R bone cements. J Arthroplasty. 1999;14:209–214
  20. Callaghan JJ, Salvati FA, Brause BD, Rimnac CM, Wright TM. Reimplantation for salvage of the infected hip: rationale for the use of gentamicin-impregnated cement and heads. The hip proceedings of the thirteenth open scientific meeting of the hip society. 1985; pp. 65–94, The Hip 1985.
  21. Scott CP, Higham PA. Antibiotic bone cement for the treatment of pseudomonas aeruginosa in joint arthroplasty: comparison of tobramycin and gentamicin-loaded cements. J Biomed Mater Res. 2003;64B:94–98
  22. Langlais F, Belot N, Ropars M, Thomazeau H, Lambotte JC, Cathelineau G. Antibiotic cements in articular prostheses: current orthopaedic concepts. Int J Antimicrob Agents. 2006;28(2):84–89
  23. Bridges SL, López-Méndez A, Han KH, Tracy IC, Alarcón GS. Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis?. J Rheumatol. 1991;18(7):984–988
  24. Hope PG, Kristinsson KG, Norman P, Elson RA. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br. 1989;71(5):851–855
  25. Sandiford A, Skinner J. Mini-Symposium: What's new in hip replacement—Basic principles: the prevention of infection in total hip arthroplasty. Orthop Trauma. 2009;23(1):8–16
  26. Coventry MB. Treatment of infections occurring in total hip surgery. Orthop Clin North Am. 1975;6:991–1003
  27. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty: a study of the treatment of one hundred and six infections. J Bone Joint Surg. 1996;78A:512–523
  28. Fitzgerald RH. Infected total hip arthroplasty: diagnosis and treatment. J Am Acad Orthop Surg. 1995;3:249–262
  29. Spangehl MJ, Masri BA, O'Connell JX, Duncan CR. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am. 1999;81:672–683
  30. Haaker R, Senge A, Kramer J, Rubenthaler F. Osteomyelitis after arthroplasty. Orthopade. 2004;33(4):431–438
  31. Lachiewicz PF, Rogers GD, Thomason HC. Aspiration of the hip joint before revision total hip arthroplasty. Clinical and laboratory factors influencing attainment of a positive culture. J Bone Joint Surg Am. 1996;78(5):749–754
  32. Kraemer WJ, Saplys R, Waddell JP, Morton J. Bone scan, gallium scan, and hip aspiration in the diagnosis of infected total hip arthroplasty. J  Arthroplasty. 1993;8(6):611–615
  33. Pakos EE, Trikalinos TA, Fotopoulos AD, Ioannidis JP. Prosthesis infection: diagnosis after total joint arthroplasty with antigranulocyte scintigraphy with 99mTc-labeled monoclonal antibodies–a meta-analysis. Radiology. 2007;242(1):101–108
  34. Lonner JH, Desai P, Dicesare PE, et al. The reliability of analysis of intraoperative frozen sections for identifying active infection during revision hip or knee arthroplasty. J Bone Joint Surg. 1996;78A:1553–1558
  35. Buchholz HW, Elson RA, Engelbrecht E, et al. Management of deep infection of total hip replacement. J Bone Joint Surg. 1981;63B:342–353
  36. Matthews PC, Dean BJ, Medagoda K, et al. Native hip joint septic arthritis in 20 adults: delayed presentation beyond three weeks predicts need for excision arthroplasty. J Infect. 2008;57(3):185–190
  37. Boeri C, Gaudias J, Jenny JY. Total hip replacement complicated by tuberculous infection. Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur. 2003;89(2):163–166
  38. Davis JS. Management of bone and joint infections due to Staphylococcus aureus. Intern Med J. 2005;35(Suppl.):79–96
  39. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–1654
  40. Moyad TF, Thornhill T, Estok D. Evaluation and management of the infected total hip and knee. Orthopedics. 2008;31(6):581–590
  41. Crockarell JR, Hansen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am. 1988;80(9):1306–1313
  42. Deirmengian C, Greenbaum J, Stern J, et al. Open debridement of acute gram-positive infections after total knee arthroplasty. Clin Orthop Relat Res. 2003;416:129–134
  43. Mitchell PA, Masri BA, Garbuz DS, Greidanus NV, Duncan CP. Cementless revision for infection following total hip arthroplasty. Instr Course Lect. 2003;52:323–330
  44. Krbec M, Cech O, Dzupa V, Pacovsky V, Klezl Z. Infection complications of total hip arthroplasty. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca. 2004;71(3):179–188
  45. Raut VV, Siney PD, Wroblewski BM. One-stage revision of total hip arthroplasty for deep infection: Long-term follow-up. Clin Orthop. 1995;321:202–207
  46. Sanzen L, Carlsson AS, Josefsson G, et al. Revision operations on infected total hip arthroplasties: Two- to nine-year follow-up study. Clin Orthop. 1988;229:165–172
  47. Hanssen AD, Osmon DR. Assessment of patient selection criteria for treatment of the infected hip arthroplasty. Clin Orthop. 2000;381:91–100
  48. Jackson WO, Schmalzried TP. Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res. 2000;381:101–105
  49. Lin J, Yang X, Bostrom MP. Two-stage exchange hip arthroplasty for deep infection. J Chemother. 2001;13(1):54–65
  50. Bottner F, Sculco TP. Infection in revision total hip arthroplasty. Techniques in Orthopaedics. 2001;16(3):310–322
  51. Lai KA, Shen WJ, Yang CY, et al. Two-stage cementless revision THR after infection. 5 recurrences in 40 cases followed 2.5–7 years. Acta Orthop Scand. 1996;67:325–328
  52. Berry DJ, Chandler HP, Reilly DT. The use of bone allografts in two-stage reconstruction after failure of hip replacement due to infection. J Bone Joint Surg. 1991;73A:1460–1468
  53. Haddad FS, Muirhead-Allwood SK, Manktelow AR, Bacarese-Hamilton I. Two-stage uncemented revision hip arthroplasty for infection. J Bone Joint Surg Br. 2000;82(5):689–694
  54. Alexeff M, Mahomed N, Morsi E, Garbuz D, Gross A. Structural allograft in two-stage revisions for failed septic hip arthroplasty. J Bone Joint Surg. 1996;78B:213–216
  55. Hofmann AA, Goldberg TD, Tanner AM, Cook TM. Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip. J Arthroplasty. 2005;20(7):874–879
  56. Younger AS, Duncan CP, Masri BA, Mc-Graw RW. The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip. J Arthroplasty. 1997;12(6):615–623
  57. Masri B, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone cement: an in vivo study using the PROSTALAC system. J Arthroplasty. 1998;13:331–338
  58. Springer BD, Lee Gwo-Chin, Osmon D, Haidukewych GJ, Hansen AD, Jacofsky DJ. Systemic safety of high-dose antibiotic loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop Relat Res. 2004;427:47–51
  59. Taggart T, Kerry RM, Norman P, Stockley I. The use of vancomycin- impregnated cement beads in the management of infection of prosthetic joints. J Bone Joint Surg. 2002;84B:70–72
  60. Burnett RJ, Kelly MA, Hanssen AD, Barrack RL. Technique and timing of two-stage exchange for infection in TKA. Clin Orthop Relat Res. 2007;464:164–178
  61. Hanssen AD, Spangehl MJ. Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res. 2004;427:79–85
  62. Duncan CP, Beauchamp C. A temporary antibiotic-loaded joint replacement system for management of complex infections involving the hip. Orthop Clin North Am. 1993;24:751–759
  63. Stockley I, Mockford BJ, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br. 2008;90(2):145–148
  64. Landor I, Vavrik P, Jahoda D. General principles of infection treatment in joint replacements. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca. 2005;72(3):183–190
  65. Goulet JA, Pellici PM, Brause BD, et al. Prolonged suppression of infection in total hip arthroplasty. J Arthroplasty. 1988;3:109–116
  66. Sharma H, De Leeuw J, Rowley DI. Girdlestone resection arthroplasty following failed surgical procedures. Int Orthop. 2005;29(2):92–95
  67. Kostuik J, Alexander D. Arthrodesis for failed arthroplasty of the hip. Clin Orthop. 1984;188:173–182
  68. Bottner F, Wegner A, Winkelmann W, Becker K, Erren M. Interleukin-6, procalcitonin and TNF-{alpha}: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br. 2007;89B/1:94–99
  69. Wirtz DC, Heller KD, Miltner O, Zilkens KW, Wolff JM. Interleukin-6: a potential inflammatory marker after total joint replacement. lnt Orthop. 2000;24:194–196
  70. Panousis K, Grigoris P, Butcher I, Rana B, Reilly JH, Hamblen DL. Poor predictive value of broad-range PCR for the detection of arthroplasty infection in 92 cases. Acta Orthop. 2005;76(3):341–346
  71. Oussedik SI, Haddad FS. The use of linezolid in the treatment of infected total joint arthroplasty. J Arthroplasty. 2008;23(2):273–278
  72. Bassetti M, Vitale F, Melica G, et al. Linezolid in the treatment of Gram-positive prosthetic joint infections. J Antimicrob Chemother. 2005;55(3):387–390
  73. Anagnostakos K, Kelm J, Grun S, Schmitt E, Jung W, Swoboda S. Antimicrobial properties and elution kinetics of linezolid-loaded hip spacers in vitro. J Biomed Mat Res - Part B Appl Biomaterials. 2008;87(1):173–178
  74. McLaren AC. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop Relat Res. 2004;427:101–106

PII: S1877-1327(09)00118-3

doi: 10.1016/j.mporth.2009.08.009

Orthopaedics and Trauma
Volume 23, Issue 5 , Pages 342-349 , October 2009

Article Tools

* Image Usage & Resolution